Preparation method of hyaluronic acid-based injectable gel loaded with modified microspheres
Patent Information
- Application Number
- CN202411037495.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-15
AI Technical Summary
[0003]市场上的抗衰老类产品目前主要有两种形式:1)外用化妆品,通过添加一些具有补充胶原蛋白、清除自由基或促进细胞新陈代谢等的活性物质来改善皮肤衰老,该方式的外用护肤品中有效活性物质的吸收率很低,效果不明显,作用时间长
[0026] 1. The present invention uses aldehyde groups and hydrazides to modify sodium hyaluronate respectively, which can spontaneously form dynamic acylhydrazone bonds under normal temperature conditions and has good stability under neutral physiological conditions; at the same time, the amino groups on the surface of the microspheres and aldehydes The base-modified sodium hyaluronate undergoes Schiff base reaction to further improve the mechanical properties and adhesive properties of the anti-aging material system. Through the preparation of the present invention, the hydrogel formed by two dynamic bonds can form a hyaluronic acid-based injectable gel loaded with modified microspheres within 84 to 104 seconds, and has excellent self-healing properties. The self-healing hydrogel gives the material instant filling and injectable capabilities, and its self-healing properties after injury provide a more sustained enhancement effect for tissue filling.
Smart Images

Figure CN118948627A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of medical cosmetology, and in particular relates to a method for preparing a hyaluronic acid-based injectable gel loaded with modified microspheres. Background Art
[0002] The skin is composed of three layers: epidermis, dermis and subcutaneous tissue. It is a natural barrier between the body and the external environment, protecting the organs in the body from the influence of the external environment. However, with the increase of age, the skin will show signs of aging, among which the changes in the dermis are the most obvious, mainly manifested as increased wrinkles and reduced elasticity. It is generally believed that one of the main mechanisms of dermal atrophy is the reduction of the amount of extracellular matrix (ECM), especially collagen, in the dermis. At present, the goal of most anti-aging methods is to reverse this process. Studies have shown that matrix metalloproteinases (MMPs) can degrade ECM proteins and are the main proteases that cause collagen fiber rupture. Reactive oxygen species (ROS) are the main driving force for the increase in MMP levels in aging skin. However, most of the current research on anti-skin aging materials only relies on foreign body reactions to stimulate collagen regeneration, such as the patent "A long-term continuous filling skin filler and its preparation method" (patent number CN117982726A) or only considers changes in the molecular level of skin components, such as the patent "An anti-aging hyaluronic acid / γ-polyglutamic acid hydrogel" (patent number CN116589709A). Even if the anti-aging methods established by the two are combined, such as in the patent "A kind of injectable skin filler and its preparation method and use" (patent number CN105749359A), a hydrophilic modified polylactic acid microsphere loaded with antioxidant factors is provided. However, researchers generally believe that the mechanism by which polymer microspheres stimulate collagen regeneration is: after subcutaneous implantation, they induce subclinical foreign body inflammatory response, stimulate fibroblasts, and promote collagen deposition. ROS is a core regulator of inflammatory signal transduction, especially in NF-κB activation and inflammasome signal transduction. How antioxidant factors can achieve anti-aging effects without affecting the foreign body reaction caused by microspheres due to their own ability to scavenge reactive oxygen species is still an unconsidered issue.
[0003] There are two main forms of anti-aging products on the market: 1) External cosmetics, which improve skin aging by adding some active substances that supplement collagen, scavenge free radicals or promote cell metabolism. The absorption rate of effective active substances in external skin care products of this type is very low, the effect is not obvious, and the duration of action is long. 2) Epidermal filling, mainly injecting botulinum toxin, hyaluronic acid, microcrystalline porcelain or poly-L-lactic acid into the skin. This method is painful and may have adverse reactions such as nodules and hematomas, and the maintenance time is limited. Therefore, it is very necessary to seek an anti-aging material with comprehensive functions that can improve the skin as a whole. For this purpose, a method for preparing a hyaluronic acid-based injectable gel loaded with modified microspheres is proposed. Summary of the invention
[0004] The object of the present invention is to provide a method for preparing a hyaluronic acid-based injectable gel loaded with modified microspheres, aiming to solve the problems raised in the above-mentioned background technology.
[0005] To achieve the above object, the present invention provides the following technical solutions:
[0006] A method for preparing a hyaluronic acid-based injectable gel loaded with modified microspheres comprises the following steps:
[0007] Step S1: Sodium hyaluronate (molecular weight ≥ 1.8 × 10 6 Da) dissolved in deionized water, and stirred magnetically until completely dissolved to obtain a sodium hyaluronate solution;
[0008] Step S2, adding solid 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide in sequence to the solution obtained in step S1, and stirring with a magnetic stirrer until completely dissolved;
[0009] Step S3, dissolving carbohydrazide in deionized water, stirring magnetically until completely dissolved, adding to the mixed solution of step S2, and stirring at room temperature overnight;
[0010] Step S4, dialyzing the mixed solution obtained in step S3 with deionized water (molecular weight cutoff 3500Da) for 3 days, and freeze-drying at -74°C (cold trap) for 12 hours to obtain hydrazide-modified sodium hyaluronate;
[0011] Step S5, adding solid sodium periodate to the solution obtained in step S1, stirring the mixture magnetically for 5 h in a dark environment at room temperature, and adding ethylene glycol to stop the reaction;
[0012] Step S6, dialyzing the mixed solution obtained in step S5 with deionized water (molecular weight cutoff 3500Da) for 3 days, and freeze-drying at -74°C (cold trap) for 12 hours to obtain aldehyde-modified sodium hyaluronate;
[0013] Step S7, dissolving the freeze-dried samples obtained in step S4 and step S6 in deionized water respectively, and stirring magnetically until completely dissolved, to obtain precursor solutions A and B;
[0014] Step S8, dissolving L-polylactic acid with a carboxyl terminal and a characteristic viscosity of 0.9 to 1.4 dL / g in an organic solvent to obtain a L-polylactic acid solution; dissolving polyethylene glycol 4000 and blue copper peptide in deionized water at 25°C, and ultrasonicating at 25°C and 40 kHz for 1 min as the inner aqueous phase (W1); dissolving polyvinyl alcohol in deionized water at 85°C, and cooling to room temperature as the outer aqueous phase (W2); rapidly pouring the L-polylactic acid solution into W1, homogenizing in an ice-water bath to obtain colostrum; dropping the obtained colostrum into W2 at a rate of 1 drop / s, homogenizing in an ice-water bath to obtain a double emulsion; magnetically stirring the obtained double emulsion at 25°C to remove the The mixture was centrifuged at 4000 rpm for 5 min, washed with deionized water for 3 times, and freeze-dried at -74 ° C (cold trap) for 12 h to obtain L-polylactic acid drug-loaded microspheres; polylysine was dissolved in deionized water, and 2 mg / mL L-polylactic acid drug-loaded microsphere suspension was added to the polylysine solution at a rate of 1 drop / s under 25 ° C and 500 rpm magnetic stirring conditions, and allowed to stand for 5 min; the supernatant was removed, deionized water was added to resuspend the microspheres, and then precipitated again, and repeated 3 times, and freeze-dried at -74 ° C (cold trap) for 12 h to obtain amino-modified L-polylactic acid microspheres loaded with blue copper peptide, with a microsphere particle size of 10-40 μm and a microsphere wall thickness of 2-4.5 μm;
[0015] Step S9, at room temperature, the precursor solutions A, B and amino-modified L-lactic acid microspheres are fully stirred and mixed to form a hyaluronic acid-based injectable gel loaded with modified microspheres within 84 to 104 seconds. The gel has the ability to release drugs on demand and meets the injection requirements of a dynamic sliding force of 0 to 7N and a maximum force of less than 14N.
[0016] Furthermore, in step S1, the mass of sodium hyaluronate is 0.4 g, and the volume of deionized water is 40 mL.
[0017] Furthermore, in step S2, the mass of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride is 0.19 g, and the mass of N-hydroxysuccinimide is 0.12 g.
[0018] Furthermore, in step S3, the mass of carbohydrazide is 0.9 g.
[0019] Furthermore, in step S5, the molar mass of sodium periodate is 0.25-1 mol, and the volume of ethylene glycol is 2-4 mL.
[0020] Furthermore, in step S7, the concentration of the precursor solution is 1-2% (w / v).
[0021] Furthermore, in the steps S1-S7, the magnetic stirring rate is 500-700 rpm.
[0022] Furthermore, in step S8, the concentration of the left-handed polylactic acid solution is 4%; the organic solvent is dichloromethane; the mass of polyethylene glycol 4000 is 50 mg, the solution concentration is 5%, the loaded drug is blue copper peptide, and the mass of blue copper peptide is 5 mg; the concentration of the polyvinyl alcohol solution is 2%; the volume ratio of the polyvinyl alcohol solution to the left-handed polylactic acid solution is 1:5; the homogenization time for preparing colostrum is 4 minutes, and the homogenization rate is 10000 rpm; the homogenization time for preparing double emulsion is 3 minutes, and the homogenization rate is 5000 rpm; the magnetic stirring rate is 500 rpm, and the time is 5 hours; the concentration of the polylysine solution is 1 mg / mL.
[0023] Furthermore, in step S9, the mixing ratio of precursor solution A and precursor solution B is 1:1, 1:2 or 2:1; the concentration of amino-modified L-polylactic acid drug-loaded microspheres is 0.1-0.5% (w / v), the size is 20-30 μm, and the wall thickness is 3.91±0.39 μm, which achieves the effect of blue copper peptide not being released in the early inflammatory stage of foreign body reaction but being released at a time in the fibrosis encapsulation stage.
[0024] A hyaluronic acid-based injectable gel loaded with modified microspheres prepared according to the preparation method described above.
[0025] Compared with the prior art, the present invention has the following beneficial effects:
[0026] 1. The present invention modifies sodium hyaluronate with aldehyde groups and hydrazides respectively, which can spontaneously form dynamic acylhydrazone bonds at room temperature and have good stability under neutral physiological conditions; at the same time, the amino groups on the surface of the microspheres react with the aldehyde-modified sodium hyaluronate to produce a Schiff base reaction, further improving the mechanical properties and bonding properties of the anti-aging material system. Through the preparation of the present invention, the hydrogel formed by the two dynamic bonds can form a hyaluronic acid-based injectable gel loaded with modified microspheres within 84 to 104 seconds, and has excellent self-healing properties. The self-healing hydrogel gives the material instant filling and injectability, and its self-repairing properties after damage provide a more sustained enhancement effect for tissue filling.
[0027] 2. The Schiff base reaction between the amino groups on the surface of the microspheres and the aldehyde-modified sodium hyaluronate further improves the mechanical properties and bonding properties of the anti-aging material system without sacrificing the self-healing properties of the material. The gel prepared by the present invention has excellent mechanical properties and is not prone to structural damage under the action of external forces; it has good tissue adhesion properties and is not easily displaced from the original injection site due to gravity and daily muscle movement, and will not cause inflammatory reactions at the distal end of the injection site, effectively avoiding additional and complex processes such as repositioning, re-injection, and removal of the structure. The tissue adhesion strength of the hyaluronic acid-based injectable gel loaded with modified microspheres prepared by the present invention is significantly higher than that of commercial fiber gels, which is further conducive to the improvement of the skin filling effect.
[0028] 3. The present invention modifies the microspheres and adjusts the concentration ratio of the modified microspheres to achieve regulation of the extrusion force during the injection process, meet the injection requirements of a dynamic sliding force of 0 to 7N and a maximum force of less than 14N, reduce pain, achieve uniform injection, and effectively avoid adverse reactions such as nodules and hematomas.
[0029] 4. The present invention loads copper peptide (blue copper peptide) into amino-modified microspheres, which can cross the skin barrier and be directly injected subcutaneously. The design of the pulse release platform provides significant protection for the stability of copper peptide, improves the absorption rate and utilization rate of copper peptide, and enhances its anti-aging effect.
[0030] 5. The gel prepared by the present invention has excellent biocompatibility. The polylysine used in the modification of the microspheres is a widely used adhesive for tissue sections and glass slides, which can further promote cell adhesion and proliferation. The gel prepared by the present invention has good safety in use. Even if an accident occurs, the hyaluronic acid-based filler can be easily removed by enzymatic degradation of hyaluronidase.
[0031] 6. In the present invention, the left-handed polylactic acid microspheres stimulate fibroblasts and promote collagen deposition by inducing a subclinical foreign body inflammatory reaction. Copper peptides are introduced into the composite system to remove reactive oxygen species and inhibit collagen degradation, thereby synergistically promoting collagen deposition at the skin molecular level. The hyaluronic acid-based injectable gel loaded with modified microspheres prepared by the present invention can achieve controlled release of drugs, that is, it can prevent the copper peptides from being released in the early inflammatory stage of the foreign body reaction, and achieve timed release in the fibrosis encapsulation stage, so that the copper peptides will not affect the foreign body reaction caused by the microspheres in the early stage of implantation due to their own removal of reactive oxygen species, and can also meet the demand for anti-aging efficacy in the later stage of implantation. Compared with the prior art, the present invention takes into account the public's many demands for the performance of anti-aging materials, and instantly composites the filling material with the stimulating regeneration material, taking into account the changes in the molecular level of skin components, and has comprehensive functions, achieving a continuous skin filling effect from the early stage of implantation to the late stage of implantation, and achieving overall improvement of aging skin. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1 The scanning electron microscope image and particle size distribution diagram of amino-modified microspheres. The upper image is a scanning electron microscope image, and the lower image is a particle size distribution diagram; in the figure, NPLLA (T) is an amino-modified L-polylactic acid microsphere loaded with blue copper peptide.
[0033] Figure 2 This is the Fourier infrared spectrum of microsphere-hyaluronic acid-based gel. In the figure, HA is sodium hyaluronate; OHA is aldehyde-modified sodium hyaluronate; NHA is hydrazide-modified sodium hyaluronate; NHO is the gel generated by the reaction of OHA and NHA; NHO / NP is the gel loaded with modified microspheres.
[0034] Figure 3 The scanning electron microscope image of microsphere-hyaluronic acid-based gel. In the image, NHO / NP is the gel loaded with modified microspheres.
[0035] Figure 4 The drug release curve of microsphere-hyaluronic acid-based gel. In the figure, NHO+PLLA(T) is a gel loaded with unmodified microspheres but loaded with blue copper peptide; NHO+NPLLA(T) is a gel loaded with modified microspheres and loaded with blue copper peptide; T is blue copper peptide.
[0036] Figure 5 The figure above is the modulus-time scan graph and quantitative data of microsphere-hyaluronic acid-based gel. The figure above is the modulus-time scan graph, and the figure below is the quantitative data. In the figure, NHO is the gel generated by the reaction of aldehyde-modified sodium hyaluronate and hydrazide-modified sodium hyaluronate; NHO+PLLA is the gel loaded with microspheres; NHO+NPLLA is the gel loaded with modified microspheres; G' is the storage modulus; G" is the loss modulus.
[0037] Figure 6 The modulus-time scanning diagram and quantitative data of modified microsphere-hyaluronic acid-based composite gel (NHO+NPLLA) with different concentrations. The upper figure is the modulus-time scanning diagram, and the lower figure is the quantitative data; 0.5%, 0.1% and 0.3% in the figure are the mass concentrations of the modified microspheres used in Examples 1-3.
[0038] Figure 7 The above figure shows the extrusion force distribution curve and quantitative data of microsphere-hyaluronic acid gel with different concentrations. The upper figure shows the extrusion force distribution curve, and the lower figure shows the extrusion force quantitative data. In the figure, PBF is the initial sliding force; F max is the maximum extrusion force; DGF is the dynamic sliding force; NHO+PLLA is the gel loaded with microspheres; NHO+NPLLA is the gel loaded with modified microspheres.
[0039] Figure 8The macroscopic self-healing graph and alternating strain scanning graph of microsphere-hyaluronic acid-based gel. The upper graph is the macroscopic self-healing graph, and the lower graph is the alternating strain scanning graph; in the graph, NHO+NPLLA is the gel loaded with modified microspheres; G' is the storage modulus; G" is the loss modulus.
[0040] Fig. 9 The adhesion curve and adhesion strength histogram of microsphere-hyaluronic acid-based gel. The upper figure is the adhesion curve, and the lower figure is the adhesion strength histogram; in the figure, NHO is the gel generated by the reaction of aldehyde-modified sodium hyaluronate and hydrazide-modified sodium hyaluronate; NHO+PLLA is the gel loaded with microspheres; NHO+NPLLA is the gel loaded with modified microspheres.
[0041] Fig.10 The stress-strain curve and maximum compressive stress histogram of microsphere-hyaluronic acid-based gel. The upper figure is the stress-strain curve, and the lower figure is the maximum compressive stress histogram; in the figure, NHO is the gel generated by the reaction of aldehyde-modified sodium hyaluronate and hydrazide-modified sodium hyaluronate; NHO+PLLA is the gel loaded with microspheres; NHO+NPLLA is the gel loaded with modified microspheres.
[0042] Fig.11 The cell live-death staining diagram of microsphere-hyaluronic acid-based gel. Among them, a is the gel group generated by the reaction of aldehyde-modified sodium hyaluronate and hydrazide-modified sodium hyaluronate; b is the gel group loaded with microspheres; c is the gel group loaded with modified microspheres; d is the gel group loaded with modified and blue copper peptide-loaded microspheres.
[0043] Fig.12 The figure is a diagram of cell proliferation of microsphere-hyaluronic acid-based gel. In the figure, NHO is a gel generated by the reaction of aldehyde-modified sodium hyaluronate and hydrazide-modified sodium hyaluronate; NHO+PLLA is a gel loaded with microspheres; NHO+NPLLA is a gel loaded with modified microspheres; NHO+NPLLA(T) is a gel loaded with modified microspheres loaded with blue copper peptide. DETAILED DESCRIPTION
[0044] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0045] The specific implementation of the present invention is described in detail below in conjunction with specific embodiments.
[0046] Example 1: A method for preparing a hyaluronic acid-based injectable gel loaded with modified microspheres provided in one embodiment of the present invention comprises the following steps:
[0047] 1) 0.4 g of cosmetic grade high molecular weight sodium hyaluronate (molecular weight ≥ 1.8 × 10 6 Da) was dissolved in 40 mL of deionized water and stirred magnetically until completely dissolved to obtain a sodium hyaluronate solution. 0.19 g and 0.12 g of solid 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride and N-hydroxysuccinimide were added to the resulting solution in sequence and stirred magnetically until completely dissolved. 0.9 g of carbohydrazide was dissolved in deionized water, stirred magnetically until completely dissolved, added to the above mixed solution and stirred overnight at room temperature. The resulting mixed solution was dialyzed with deionized water (molecular weight cutoff 3500 Da) for 3 days and freeze-dried at -74 ° C (cold trap) for 12 hours to obtain hydrazide-modified sodium hyaluronate.
[0048] 2) Add 0.5 mol of solid sodium periodate to the sodium hyaluronate solution, stir magnetically for 5 h in a dark environment at room temperature, and add 2 mL of ethylene glycol to stop the reaction. The resulting mixed solution is dialyzed with deionized water (molecular weight cutoff 3500 Da) for 3 days, and freeze-dried at -74°C (cold trap) for 12 h to obtain aldehyde-modified sodium hyaluronate.
[0049] 3) The hydrazide-modified sodium hyaluronate and the aldehyde-modified sodium hyaluronate freeze-dried samples were dissolved in deionized water, respectively, and magnetically stirred until completely dissolved to obtain precursor solutions A and B with a concentration of 2% (w / v). 0.2 g of L-polylactic acid with a carboxyl terminal and an intrinsic viscosity of 0.9-1.4 dL / g was dissolved in 5 mL of dichloromethane (4%, w / v) to obtain a L-polylactic acid solution as the oil phase (O); 50 mg of polyethylene glycol 4000 and 5 mg of blue copper peptide were dissolved in 1 mL of deionized water at 25°C, and ultrasonicated at 25°C and 40 kHz for 1 min as the inner water phase (W1); 0.5 g of polyvinyl alcohol was dissolved in 25 mL of deionized water (2%, w / v) at 85°C, and cooled to room temperature as the outer water phase (W2). The prepared L-polylactic acid solution was quickly poured into W1, and homogenized at 10000 rpm for 4 min in an ice-water bath to obtain colostrum. The obtained colostrum solution was added dropwise to W2 at a rate of 1 drop / s, and homogenized at 5000 rpm for 3 min in an ice-water bath to obtain a double emulsion. The obtained double emulsion was magnetically stirred at 500 rpm for 5 h at 25 ° C to remove dichloromethane, centrifuged at 4000 rpm for 5 min, washed with deionized water 3 times, and freeze-dried at -74 ° C (cold trap) for 12 h to obtain L-polylactic acid drug-loaded microspheres.
[0050] 4) Dissolve 10 mg of polylysine in 10 mL of deionized water (the concentration of the polylysine solution is 1 mg / mL), and add 2 mg / mL of microsphere suspension to the polylysine solution at a rate of 1 drop / s at 25°C and 500 rpm magnetic stirring, and let stand for 5 minutes. Remove the supernatant, add deionized water to resuspend the microspheres, and precipitate again. Repeat 3 times and freeze-dry at -74°C (cold trap) for 12 hours to obtain amino-modified L-polylactic acid-loaded blue copper peptide microspheres.
[0051] 5) At room temperature, the precursor solutions A and B and 0.5% (w / v) amino-modified L-lactic acid drug-loaded microspheres were thoroughly stirred and mixed in a ratio of 1:1, and a hyaluronic acid-based injectable gel loaded with modified microspheres was formed after 84 seconds.
[0052] In the embodiment of the present invention, the microsphere-hyaluronic acid-based composite gel is characterized as follows:
[0053] (1) Morphological characterization and particle size analysis of amino-modified microspheres;
[0054] The internal morphology of the modified microspheres was observed by scanning electron microscopy. Figure 1 The microspheres are hollow inside with a wall thickness of 3.91±0.39μm. The particle size of the microspheres under scanning electron microscope was analyzed by ImageJ, and the particle size distribution of the microspheres was plotted. The results are shown in Figure 1 As shown in the figure below, the particle size of the microspheres is mainly concentrated between 20 and 30 μm.
[0055] (2) infrared characterization of microsphere-hyaluronic acid-based gel;
[0056] Fourier transform infrared spectroscopy was used to characterize the microsphere-hyaluronic acid-based gel. About 1 mg of the sample was mixed with 100-200 mg of dry potassium bromide in an agate mortar and ground thoroughly. The sample was pressed into an almost transparent sheet using a tablet press and placed in a sample holder. The sample was then inserted into a fixed position in the instrument sample chamber for detection. The absorption spectrum of the sample was between 500 and 4000 cm -1 4cm between -1 A total of 64 scans were performed, and the results are shown in Figure 2 , 1657cm -1 The peak at 400 nm confirmed the successful preparation of the gel.
[0057] (3) morphological analysis of microsphere-hyaluronic acid-based gel;
[0058] The morphology of the microsphere-hyaluronic acid-based gel was observed using a scanning electron microscope. Figure 3 As shown in Figure 2, the hydrogel exhibits an irregular porous microstructure with relatively smooth pore walls and obvious microspheres can be observed in the pores.
[0059] (4) Analysis of drug release kinetics of microsphere-hyaluronic acid-based gel;
[0060] The in vitro drug release profile of microsphere-hyaluronic acid-based gel was studied using bovine serum albumin (BSA) as a model drug. Figure 4 The gel NHO+NPLLA(T) showed strong pulsed drug release on days 19 to 21, i.e., the fiber embedding stage of foreign body reaction, while the initial burst release was negligible, proving that the controlled release system of the present invention achieved delayed and timed drug release and could not affect the early inflammatory response stage of foreign body reaction due to the drug's ability to scavenge active oxygen.
[0061] (5) Analysis of gelation time of microsphere-hyaluronic acid-based gel;
[0062] The gelation time of microsphere-hyaluronic acid-based gels was evaluated by rheological testing, e.g. Figure 5 and Figure 6 As shown. The storage modulus of the hydrogel increases rapidly and is higher than the loss modulus in a short time, indicating that the hydrogel is formed rapidly. After adding PLLA microspheres to the NHO hydrogel, the gelation point (G′=G″) changes from 115s to 134s, indicating that the addition of PLLA microspheres hinders the cross-linking of the system. On the contrary, after the introduction of modified microspheres NPLLA, the gelation point changes from 115s to 104s, and the gelation time of the hydrogel is significantly shortened, and continues to decrease to 84s with the increase of NPLLA concentration.
[0063] (6) Analysis of the extrusion force required for injection of microsphere-hyaluronic acid-based gels with different concentrations;
[0064] The injectability of the composite gel was evaluated by a universal testing machine to measure the initial sliding force, maximum force, and dynamic sliding force, respectively, as Figure 7 As the concentration of modified microspheres increased from 0.1% to 0.7% (w / v), the maximum force required for injection (F max ) increased from 1.33±0.10N to 11.49±0.24N, and the dynamic sliding force (DGF) required for injection increased from 1.30±0.17N to 8.06±1.35N. Therefore, when the concentration of modified microspheres is 0.1-0.5% (w / v), the composite filler always meets the injection requirements of a maximum force of less than 14N and a dynamic sliding force of 0-7N. However, the extrusion force required for the composite hydrogel to which unmodified microspheres are added is much higher than that of the composite hydrogel containing the maximum concentration of amino-modified microspheres. There may even be a phenomenon of separation of the needle from the syringe during the injection process because the particle size of the microsphere aggregates exceeds the inner diameter of the needle. This shows the superiority of the anti-aging material proposed in the present invention, which greatly reduces pain, bleeding and the risk of tissue damage in clinical practice.
[0065] (7) Analysis of the self-healing properties of microsphere-hyaluronic acid-based gel;
[0066] At room temperature, two sheets of hydrogel were placed in contact along the cut line. Figure 8 As shown, without any external stimulation, the two hydrogels healed into a whole. Although the cutting line was clearly visible, the fused hydrogel was able to withstand tension without breaking. Alternating strain tests showed that the hydrogels exhibited continuous liquid-solid transition behavior under alternating strains of 1% and 500%, and the recovery value of the hydrogel G' under low strain exceeded 95% of the original value. The results show that the microsphere-hyaluronic acid-based composite gel has excellent self-healing properties.
[0067] (8) Mechanical properties analysis of microsphere-hyaluronic acid-based gel;
[0068] The gel was sandwiched between two pieces of pig skin, and its adhesion strength was measured using a lap shear test, e.g. Fig. 9 As shown. After adding modified microspheres, the adhesion strength of NHO+NPLLA hydrogel increased significantly and was higher than that of commercial fiber gel (12.1±3.5kPa). The compressive strength of the composite hydrogel was tested using a universal testing machine, as shown in Fig.10 As shown in the figure, consistent with the adhesion strength test results, the compressive strength of NHO+NPLLA hydrogel was significantly improved after adding modified microspheres. The experimental results show that microsphere-hyaluronic acid-based gel has good mechanical properties and can provide excellent instant filling effect.
[0069] (9) Biocompatibility analysis of microsphere-hyaluronic acid-based gel;
[0070] The biocompatibility of the hydrogels was evaluated by testing their cytotoxicity against mouse fibroblasts. Fig.11 and Fig.12 Live / dead staining ( Fig.11 ) and cell proliferation ( Fig.12 ) The experimental results showed that the cells co-cultured with the microsphere-hyaluronic acid-based gel exhibited a higher survival rate, indicating that the gel had no obvious cytotoxicity and would not cause adverse reactions in practical applications.
[0071] Example 2: A method for preparing a hyaluronic acid-based injectable gel loaded with modified microspheres provided in one embodiment of the present invention comprises the following steps:
[0072] 1) Same as step 1) in Example 1.
[0073] 2) Add 1 mol of solid sodium periodate to the sodium hyaluronate solution, stir magnetically for 5 h in a dark environment at room temperature, and add 4 mL of ethylene glycol to stop the reaction. The resulting mixed solution is dialyzed with deionized water (molecular weight cutoff 3500 Da) for 3 days, and freeze-dried at -74°C (cold trap) for 12 h to obtain aldehyde-modified sodium hyaluronate.
[0074] 3) Same as step 3) in Example 1.
[0075] 4) Same as step 4) in Example 1.
[0076] 5) At room temperature, the precursor solutions A and B and 0.1% (w / v) amino-modified L-lactic acid drug-loaded microspheres were stirred and mixed in a ratio of 2:1. After 104 seconds, a hyaluronic acid-based injectable gel loaded with modified microspheres was formed. Figure 6 shown.
[0077] Example 3: A method for preparing a hyaluronic acid-based injectable gel loaded with modified microspheres provided in one embodiment of the present invention comprises the following steps:
[0078] 1) Same as step 1) in Example 1.
[0079] 2) Add 0.25 mol of solid sodium periodate to the sodium hyaluronate solution, stir magnetically for 5 h in a dark environment at room temperature, and add 2 mL of ethylene glycol to stop the reaction. The resulting mixed solution is dialyzed with deionized water (molecular weight cutoff 3500 Da) for 3 days, and freeze-dried at -74°C (cold trap) for 12 h to obtain aldehyde-modified sodium hyaluronate.
[0080] 3) The difference from step 3) in Example 1 is that the freeze-dried samples of hydrazide-modified sodium hyaluronate and aldehyde-modified sodium hyaluronate are dissolved in deionized water respectively, and magnetically stirred until completely dissolved to obtain precursor solutions A and B with a concentration of 1% (w / v). The other steps are the same as step 3) in Example 1.
[0081] 4) Same as step 4) in Example 1.
[0082] 5) At room temperature, the precursor solutions A and B and 0.3% (w / v) amino-modified L-lactic acid drug-loaded microspheres were stirred and mixed in a ratio of 1:2. After 92 seconds, a hyaluronic acid-based injectable gel loaded with modified microspheres was formed. Figure 6 shown.
[0083] The above are only preferred embodiments of the present invention. It should be pointed out that, for those skilled in the art, several modifications and improvements can be made without departing from the concept of the present invention. These should also be regarded as the protection scope of the present invention. These will not affect the effect of the implementation of the present invention and the practicality of the patent.
Claims
1. A method for preparing a hyaluronic acid-based injectable gel loaded with modified microspheres, characterized in that: The following steps are involved: Step S1: molecular weight ≥ 1.8 × 10 6 Da's cosmetic grade high molecular weight sodium hyaluronate was dissolved in deionized water and magnetically stirred until completely dissolved to obtain a sodium hyaluronate solution; Step S2, adding solid 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide in sequence to the solution obtained in step S1, and stirring with a magnetic stirrer until completely dissolved; Step S3, dissolving carbohydrazide in deionized water, stirring magnetically until completely dissolved, adding to the mixed solution of step S2, and stirring at room temperature overnight; Step S4, dialyzing the mixed solution obtained in step S3 with deionized water for 3 days, and freeze-drying at -74°C for 12 hours to obtain hydrazide-modified sodium hyaluronate; Step S5, adding solid sodium periodate to the solution obtained in step S1, stirring the mixture magnetically for 5 h in a dark environment at room temperature, and adding ethylene glycol to stop the reaction; Step S6, dialyzing the mixed solution obtained in step S5 with deionized water for 3 days, and freeze-drying at -74°C for 12 hours to obtain aldehyde-modified sodium hyaluronate; Step S7, dissolving the freeze-dried samples obtained in step S4 and step S6 in deionized water respectively, and stirring magnetically until completely dissolved, to obtain precursor solutions A and B; Step S8, dissolving L-polylactic acid with a carboxyl terminal and a characteristic viscosity of 0.9 to 1.4 dL / g in an organic solvent to obtain a L-polylactic acid solution; dissolving polyethylene glycol 4000 and blue copper peptide in deionized water at 25°C, and ultrasonicating at 25°C and 40 kHz for 1 min as W1; dissolving polyvinyl alcohol in deionized water at 85°C, and cooling to room temperature as W2; rapidly pouring the L-polylactic acid solution into W1, homogenizing in an ice-water bath to obtain colostrum; dropping the obtained colostrum into W2 at a rate of 1 drop / s, homogenizing in an ice-water bath to obtain a double emulsion; magnetically stirring the obtained double emulsion at 25°C to remove the organic Solvent, centrifuge at 4000rpm for 5min, wash with deionized water 3 times, and freeze-dry at -74℃ for 12h to obtain L-polylactic acid drug-loaded microspheres; dissolve polylysine in deionized water, add 2mg / mL L-polylactic acid drug-loaded microsphere suspension to the polylysine solution at a rate of 1 drop / s under 25℃ and 500rpm magnetic stirring conditions, and let stand for 5min; remove the supernatant, add deionized water to resuspend the microspheres, precipitate again, repeat 3 times, and freeze-dry at -74℃ for 12h to obtain amino-modified L-polylactic acid microspheres loaded with blue copper peptide, with a microsphere particle size of 10-40μm and a microsphere wall thickness of 2-4.5μm; Step S9: Under room temperature, the precursor solutions A and B and the amino-modified L-polylactic acid microspheres are fully stirred and mixed to form a hyaluronic acid-based injectable gel loaded with the modified microspheres within 84 to 104 seconds.
2. The preparation method according to claim 1, characterized in that: In step S1, the mass of sodium hyaluronate is 0.4 g, and the volume of deionized water is 40 mL.
3. The preparation method according to claim 1, characterized in that: In the step S2, the mass of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride is 0.19 g, and the mass of N-hydroxysuccinimide is 0.12 g.
4. The preparation method according to claim 1, characterized in that: In step S3, the mass of carbohydrazide is 0.9 g.
5. The preparation method according to claim 1, characterized in that: In the step S5, the molar mass of sodium periodate is 0.25-1 mol, and the volume of ethylene glycol is 2-4 mL.
6. The preparation method according to claim 1, characterized in that: In the step S7, the concentration of the precursor solution is 1-2% (w / v).
7. The preparation method according to claim 1, characterized in that: In the step S8, the concentration of the left-handed polylactic acid solution is 4%; the organic solvent is dichloromethane; the mass of polyethylene glycol 4000 is 50 mg, the solution concentration is 5%, the loaded drug is blue copper peptide, and the mass of blue copper peptide is 5 mg; the concentration of the polyvinyl alcohol solution is 2%; the volume ratio of the polyvinyl alcohol solution to the left-handed polylactic acid solution is 1:5; the homogenization time when preparing colostrum is 4 minutes, and the homogenization rate is 10000 rpm; the homogenization time when preparing double emulsion is 3 minutes, and the homogenization rate is 5000 rpm; the magnetic stirring rate is 500 rpm, and the time is 5 hours; the concentration of the polylysine solution is 1 mg / mL.
8. The preparation method according to claim 1, characterized in that: In step S9, the mixing ratio of precursor solution A to precursor solution B is 1:1, 1:2 or 2:1; the concentration of amino-modified L-polylactic acid drug-loaded microspheres is 0.1-0.5% (w / v), the size is 20-30 μm, and the wall thickness is 3.91±0.39 μm.
9. A hyaluronic acid-based injectable gel loaded with modified microspheres prepared according to the preparation method of any one of claims 1 to 8.
Citation Information
Cited By
Polylactic acid composite freeze-dried powder for injection and preparation method thereof
CN120939294A
A polylactic acid composite lyophilized powder for injection and a method of preparation
CN120939294B
Self-assembly microsphere array with adjustable and stable pores as well as preparation method and application of self-assembly microsphere array
CN121846350A
